ReviewImmune network2026
Homeostatic Regulation of Lung Dendritic Cells at Steady State.
Review in Immune network, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The lung immune system is uniquely adapted to sustain continuous exposure to environmental stimuli while avoiding excessive inflammation. Among lung-resident immune cells, alveolar macrophages are well recognized as key regulators of immune quiescence and tissue homeostasis under steady-state conditions. In contrast, the roles of dendritic cells (DCs), another population of resident immune cells, have received comparatively less attention, likely owing to their lower abundance within the lung tissue. Nevertheless, as professional antigen-presenting cells and central orchestrators of adaptive immunity, DCs are critically positioned to determine the balance between immune tolerance and activation in the lung. Recent studies have increasingly highlighted the contribution of lung DCs to the pathogenesis of inflammatory and neoplastic lung diseases, including allergy, asthma, and cancer. However, how DCs are positioned, conditioned, and functionally regulated under steady-state conditions remains incompletely understood. In this review, we focus on spatial organization, cellular interactions, and microenvironmental cues that shape lung DC behavior at steady-state and delineate how these homeostatic programs preserve immune tolerance while maintaining immune readiness.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.